ROE reveals what percentage of each investment dollar is returned as a profit. It is also a key component used to calculate the price-to-earnings valuation (P/E) ratio. The consensus rating is 2, indicating analysts in general look favorably on the company's future prospects. For the stock, price target value has been calculated at $4.50.
Home Depot Inc shares slipped 1.6 per cent after the home improvement retailer missed sales forecasts as the long winter put a damper on demand for spring products. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Company's price to free cash flow for trailing twelve months is N/A.
One of the most popular ratios is the "Return on Assets" (aka ROA).
At the time of writing, OncoSec Medical Incorporated (NasdaqCM:ONCS) has a Piotroski F-Score of 2. To know the company's net income - refer to this link: http://finviz.com. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return. This M-score model was developed by Messod Beneish in order to detect manipulation of financial statements. OncoSec Medical Incorporated (NasdaqCM:ONCS) has an M-Score of -999.
ONCS's Beta value is 3.03.
Investors may be interested in viewing the Gross Margin score on shares of OncoSec Medical Incorporated (NasdaqCM:ONCS).
ALSK's Beta value is 0.09.
Shifting gears, we can see that OncoSec Medical Incorporated (NasdaqCM:ONCS) has a Q.i. Home Depot fell 1.5 percent in midday trading. The MF Rank of OncoSec Medical Incorporated (NasdaqCM:ONCS) is 18598. The ERP5 Rank may assist investors with spotting companies that are undervalued. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, "The Little Book that Beats the Market".
The decline in USA equities came after Home Depot stated first-quarter earnings that beat Wall Street's expectations, but its sales missed estimates thanks to what the company categorized as a "slow start" to spring sales. Still, many investors are fond of using the concept of Forward P/E and Forward PEG ratio. Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. Analysts predict $-0.14 EPS, which is $0.08 up or 36.36 % from 2017's $-0.22 EPS. At the moment, the company has a debt-to-equity ratio of 0.00, a current ratio of 6.70, and a quick ratio of 6.70. Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value.
HC Wainwright set a $4.00 price objective on OncoSec Medical (NASDAQ:ONCS) in a report issued on Wednesday, May 9th. Rodman & Renshaw analysts Resumed the shares of OncoSec Medical Incorporated to Buy in a research note they presented on July 21st, 2016, but they now have set a price target of $6. Commonwealth Equity Services LLC now owns 76,510 shares of the biotechnology company's stock worth $143,000 after purchasing an additional 37,800 shares during the period. If the ratio is greater than 1, then that means there has been an increase in price over the month. A ratio lower than one shows that the price has decreased over that time period. The stock deteriorated -9.04% during the past three month period and discounted -24.34% in half year. OncoSec Medical has a twelve month low of $1.58 and a twelve month high of $1.67.
Some of the best financial predictions are formed by using a variety of financial tools. The company's distance from 52-week high price is -40.34% and current price is above +100.00% from 52-week low price. The Price Range of OncoSec Medical Incorporated (NasdaqCM:ONCS) over the past 52 weeks is 0.674.